• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Antibiotic potentiators against drug-resistant pathogens: Discovery, development and clinical applications.

作者信息

Das Bhabatosh, Mahajan Dinesh, Rakonjac Jasna

机构信息

Centre for Bacterial Diseases and Antibiotic Resistance Research, Translational Health Science and Technology Institute, Faridabad, India.

Chemistry and Pharmacology Lab, Centre for Drug Design and Discovery, Translational Health Science and Technology Institute, Faridabad, India.

出版信息

Front Microbiol. 2023 Mar 7;14:1173906. doi: 10.3389/fmicb.2023.1173906. eCollection 2023.

DOI:10.3389/fmicb.2023.1173906
PMID:36960280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10028237/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f65/10028237/807d7ebbec1f/fmicb-14-1173906-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f65/10028237/807d7ebbec1f/fmicb-14-1173906-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f65/10028237/807d7ebbec1f/fmicb-14-1173906-g0001.jpg

相似文献

1
Editorial: Antibiotic potentiators against drug-resistant pathogens: Discovery, development and clinical applications.社论：抗耐药病原体的抗生素增效剂：发现、开发与临床应用
Front Microbiol. 2023 Mar 7;14:1173906. doi: 10.3389/fmicb.2023.1173906. eCollection 2023.
2
β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward.β-内酰胺增效剂使耐药病原体重新敏感：发现、开发、临床应用及未来方向
Front Microbiol. 2023 Mar 10;13:1092556. doi: 10.3389/fmicb.2022.1092556. eCollection 2022.
3
Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance.抗多重耐药菌的抗生素增效剂：发现、研发及临床意义
Front Microbiol. 2022 Jul 1;13:887251. doi: 10.3389/fmicb.2022.887251. eCollection 2022.
4
Advances in the Discovery of Efflux Pump Inhibitors as Novel Potentiators to Control Antimicrobial-Resistant Pathogens.外排泵抑制剂作为控制抗菌耐药病原体的新型增效剂的发现进展
Antibiotics (Basel). 2023 Sep 7;12(9):1417. doi: 10.3390/antibiotics12091417.
5
Precision Dosing of Antibiotics and Potentiators by Hypoxia-Responsive Nanoparticles for Overcoming Antibiotic Resistance in Gram-Negative Bacteria.缺氧响应性纳米颗粒精准给药抗生素和增效剂以克服革兰氏阴性菌的抗生素耐药性
ACS Macro Lett. 2023 Sep 19;12(9):1193-1200. doi: 10.1021/acsmacrolett.3c00365. Epub 2023 Aug 17.
6
Small-Molecule Potentiators for Conventional Antibiotics against Staphylococcus aureus.用于传统抗生素对抗金黄色葡萄球菌的小分子增效剂。
ACS Infect Dis. 2017 Nov 10;3(11):780-796. doi: 10.1021/acsinfecdis.7b00084. Epub 2017 Oct 4.
7
Antibiotic Potentiation as a Promising Strategy to Combat Macrolide Resistance in Bacterial Pathogens.抗生素增效作为对抗细菌病原体大环内酯类耐药性的一种有前景的策略。
Antibiotics (Basel). 2023 Dec 11;12(12):1715. doi: 10.3390/antibiotics12121715.
8
Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria.β-内酰胺酶抑制剂作为增效剂在针对革兰氏阴性菌的抗菌化疗中的作用。
Antibiotics (Basel). 2024 Mar 15;13(3):260. doi: 10.3390/antibiotics13030260.
9
A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids.一项关于重症监护病房医院病原体的研究，特别涉及携带多个质粒的多重耐药鲍曼不动杆菌。
Indian J Med Res. 2008 Aug;128(2):178-87.
10
Naphthyl-Substituted Indole and Pyrrole Carboxylic Acids as Effective Antibiotic Potentiators-Inhibitors of Bacterial Cystathionine γ-Lyase.萘基取代吲哚和吡咯羧酸作为有效的抗生素增效剂-细菌胱硫醚γ-裂解酶抑制剂。
Int J Mol Sci. 2023 Nov 15;24(22):16331. doi: 10.3390/ijms242216331.

引用本文的文献

1
Novel Antibacterial Approaches and Therapeutic Strategies.新型抗菌方法与治疗策略
Antibiotics (Basel). 2025 Apr 15;14(4):404. doi: 10.3390/antibiotics14040404.

本文引用的文献

1
β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward.β-内酰胺增效剂使耐药病原体重新敏感：发现、开发、临床应用及未来方向
Front Microbiol. 2023 Mar 10;13:1092556. doi: 10.3389/fmicb.2022.1092556. eCollection 2022.
2
Molecular mechanisms of antibiotic resistance revisited.抗生素耐药性的分子机制再探讨。
Nat Rev Microbiol. 2023 May;21(5):280-295. doi: 10.1038/s41579-022-00820-y. Epub 2022 Nov 21.
3
Region-specific genomic signatures of multidrug-resistant Helicobacter pylori isolated from East and South India.
来自印度东部和南部的多药耐药幽门螺杆菌的区域特异性基因组特征。
Gene. 2022 Dec 30;847:146857. doi: 10.1016/j.gene.2022.146857. Epub 2022 Sep 11.
4
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担：系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
5
Antimicrobial resistance and virulence in Helicobacter pylori: Genomic insights.幽门螺杆菌的抗菌耐药性与毒力：基因组学见解
Genomics. 2021 Nov;113(6):3951-3966. doi: 10.1016/j.ygeno.2021.10.002. Epub 2021 Oct 5.
6
Antibiotic resistance in Vibrio cholerae: Understanding the ecology of resistance genes and mechanisms.霍乱弧菌的抗生素耐药性：耐药基因和机制的生态学研究。
Vaccine. 2020 Feb 29;38 Suppl 1:A83-A92. doi: 10.1016/j.vaccine.2019.06.031. Epub 2019 Jul 2.
7
Molecular Insights into Antimicrobial Resistance Traits of Multidrug Resistant Enteric Pathogens isolated from India.印度分离的多重耐药肠道病原体的抗菌耐药特性的分子研究。
Sci Rep. 2017 Oct 31;7(1):14468. doi: 10.1038/s41598-017-14791-1.
8
Fostering research into antimicrobial resistance in India.促进印度抗菌药物耐药性研究。
BMJ. 2017 Sep 6;358:j3535. doi: 10.1136/bmj.j3535.